The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.
about
History of clinical transplantationThe unfinished legacy of liver transplantation: emphasis on immunology.Themes of liver transplantation.Selected topics on antilymphocyte serum.Acquired immunologic tolerance: with particular reference to transplantationTherapeutic drug monitoring of immunosuppressant drugs.Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles.Factors in the Development of Liver Transplantation.Liver transplantation: an unfinished productAnimal research in liver transplantation with special reference to the dog.Body temperature changes during organ transplantation.A new liver perfusion and preservation system for transplantation research in large animals.FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in ratsExperience with Orthoclone OKT3 monoclonal antibody in liver transplantation.Extended survival in 3 cases of orthotopic homotransplantation of the human liverCell migration and chimerism after whole-organ transplantation: the basis of graft acceptanceFrance and the early history of organ transplantationImmunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.Liver transplantation in the ciclosporin era.Organ transplantation, past and present.Evolution of liver transplantation.Organ transplantation--then and nowImmunosuppression and other nonsurgical factors in the improved results of liver transplantation.Lessons of organ-induced tolerance learned from historical clinical experienceSuppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy.Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.Human renal transplants. 3. Immunopathologic studies.The current status of hepatic transplantation at the University of PittsburghThe development of clinical renal transplantation.The mystique of organ transplantation.Transplantation milestones. Viewed with one- and two-way paradigms of tolerance.The birth of clinical organ transplantation.Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntletThe transplantation of gastrointestinal organs.Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.ORTHOCLONE OKT3 in Treatment of Allografts Rejected Under Cyclosporine-Steroid TherapySteps in immunosuppression for renal transplantation.Liver and kidney transplantation in children receiving cyclosporin A and steroids.Transplantation tolerance from a historical perspective.Pancreas and islet cell transplantation.
P2860
Q24596303-6D63DE4E-C463-457E-8C61-C88E73A31B07Q30352760-88214C16-2B40-4AAD-B8F2-7381ACA02FB1Q30658256-377BA430-BB87-441F-85CE-98A691F6E78BQ33467450-E0172ED6-5D48-44E5-9EE8-059BEF894B91Q33567138-98E0B1C9-E9F0-4F03-8689-6CBC1C0B60F2Q33610775-D3F946D3-F203-4111-9707-9FCFF0C7C408Q33930853-3E7365E4-532A-49B5-8B8C-7882E6DB859BQ33993337-3D2B5919-5A94-4EC0-AF45-3D560CDA9DB8Q34177197-ABB1B1D6-1C91-4A93-A70A-BE1F1F19AA85Q34201191-933F12DD-96DF-4BC9-B56F-F0A9E2693C3DQ34201776-227157DE-8C1C-4512-9C16-D3BD632294F7Q34207294-CF2B3EA7-9296-498D-A660-C7C1E68531DBQ34207804-E32F91F7-A423-446A-BBF9-1FED6F7EF614Q34219725-4BCEE64D-F3BE-4D6D-8AFD-9854C1AC1EC4Q34240884-5BFF4091-EC08-47E5-98D4-341AC9D892E4Q34241674-A1D7C4EE-9EEF-4EE6-96D7-1A8A0721CDB5Q34248985-8674F6B6-ABFE-49C0-8B87-5B96642AFC08Q34275070-E3AD97C5-2A09-49FE-AC47-A1452E88B2E9Q34275290-7D7AAB8F-9323-417E-B929-7FA154FC0AF2Q34275572-567266E1-DC0B-4476-BBD0-C5CFAE218B07Q34275840-9186D038-6AD9-4F35-B85A-DB5F4AEC7609Q34286210-A10F46D4-CAAE-4BE5-BE2E-041D6990C452Q34286455-D5BBCA20-A66E-47CF-8A4C-06F8FE427F6FQ34294947-DC727885-E15B-46A4-9298-AAA89CC4992EQ34298815-5F1237F8-06F5-40AC-9CCB-F819A0CF3492Q34304820-F19381A5-A34A-453F-B213-95A56744F26CQ34305056-35CAEA94-A4FD-4881-B19A-17C3CC49F47DQ34330449-DE6F319E-DEEB-419F-9BA2-98FC2ACC2223Q34330601-A6507B7C-A74F-40CF-A4D8-C31EE2ACC121Q34330774-B9C7AE20-3BC5-4E21-968E-FC95B6049673Q34334037-4778D267-DA52-43DC-A17B-D9650BBE58CAQ34340940-610014B1-70F0-4EE8-9D4D-45C45FF6C648Q34340969-56F46EC7-FF2A-4685-9518-0D48E11C0CEAQ34346753-4310C2C5-CCFE-4F25-A5AC-7FEE39DA7B9DQ34359751-C6BE731C-05F2-4474-8AEC-CF4105B38434Q34396283-FB9CE829-33F5-46DF-860B-649BE684A922Q34497811-C3810E25-44CB-4E33-88F3-25E02D87406BQ34561587-60A1FEB7-A5F5-41B8-B8D6-7E0C1E3EAE21Q34572212-CCB703C0-1CAE-42F0-8FFC-C73880F4EA9EQ34701213-70642849-79E6-42BF-A06C-136DB8DF6970
P2860
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1967
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of heterologous antily ...... man renal homotransplantation.
@en
The use of heterologous antily ...... man renal homotransplantation.
@nl
type
label
The use of heterologous antily ...... man renal homotransplantation.
@en
The use of heterologous antily ...... man renal homotransplantation.
@nl
prefLabel
The use of heterologous antily ...... man renal homotransplantation.
@en
The use of heterologous antily ...... man renal homotransplantation.
@nl
P2093
P2860
P1476
The use of heterologous antily ...... uman renal homotransplantation
@en
P2093
G J Cerilli
K A Porter
T L Marchioro
P2860
P304
P577
1967-02-01T00:00:00Z